Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Current Leases (2023 - 2025)

CG Oncology filings provide 3 years of Current Leases readings, the most recent being $915000.0 for Q4 2025.

  • On a quarterly basis, Current Leases rose 391.94% to $915000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $915000.0, a 391.94% increase, with the full-year FY2025 number at $915000.0, up 391.94% from a year prior.
  • Current Leases hit $915000.0 in Q4 2025 for CG Oncology, roughly flat from $912000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $915000.0 in Q4 2025 to a low of $186000.0 in Q4 2024.
  • Median Current Leases over the past 3 years was $237000.0 (2024), compared with a mean of $383888.9.
  • Biggest five-year swings in Current Leases: fell 14.29% in 2024 and later surged 391.94% in 2025.
  • CG Oncology's Current Leases stood at $217000.0 in 2023, then dropped by 14.29% to $186000.0 in 2024, then surged by 391.94% to $915000.0 in 2025.
  • The last three reported values for Current Leases were $915000.0 (Q4 2025), $912000.0 (Q3 2025), and $288000.0 (Q2 2025) per Business Quant data.